AI
ARIA

Axiom Investors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Axiom Investors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-87,952
Closed -$514K – 149
2015
Q3 		$514K Sell
87,952
-79,845
-48% -$615K 0.02% 121
2015
Q2 		$1.39M Buy
+167,797
New +$1.48M 0.04% 117
2014
Q3 		– Sell
-68,600
Closed -$437K – 180
2014
Q2 		$437K Hold
68,600
– – 0.01% 147
2014
Q1 		$553K Buy
+68,600
New +$534K 0.01% 147

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Axiom Investors's ARIA Position: Q4 2015 in Review

Axiom Investors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2015, closing a stake of 87,952 shares — an estimated $514K sold.

Axiom Investors first reported a position in ARIA in Q1 2014 and held it in 4 quarters. The position peaked at $1.39M in Q2 2015. 172 funds tracked by Wall St. Rank hold ARIA as of Q4 2015.

  • Axiom Investors reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Axiom Investors sold 87,952 Ariad Pharmaceuticals Inc shares in Q4 2015, an estimated $514K.
  • Axiom Investors first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 4 quarters.
  • Axiom Investors's Ariad Pharmaceuticals Inc position peaked at $1.39M in Q2 2015.
  • 172 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2015.

Based on Axiom Investors's 13F filing for Q4 2015, filed 12 Feb 2016.